Page last updated: 2024-08-21

dihydroergotamine and Genital Neoplasms, Female

dihydroergotamine has been researched along with Genital Neoplasms, Female in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wille, P1
Gorisek, B; Jelatancev, B; Urlep-Salinović, V1
Madzhuga, AV; Maslikhova, VN; Pavlova, ZV; Somonova, OV; Zaĭtseva, TI1

Trials

2 trial(s) available for dihydroergotamine and Genital Neoplasms, Female

ArticleYear
Prevention of postoperative thromboembolism in gynaecological malignancy.
    European journal of gynaecological oncology, 1993, Volume: 14, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Dihydroergotamine; Drug Combinations; Female; Genital Neoplasms, Female; Heparin; Humans; Incidence; Middle Aged; Postoperative Complications; Prospective Studies; Risk Factors; Thromboembolism

1993
[Prevention of postoperative thrombotic complications by a combination of small doses of heparin and digitamin in oncologic patients].
    Rossiiskii meditsinskii zhurnal : organ Ministerstva zdravookhraneniia RSFSR, 1992, Issue:3

    Topics: Dihydroergotamine; Drug Combinations; Female; Genital Neoplasms, Female; Heparin; Heparin, Low-Molecular-Weight; Humans; Postoperative Complications; Thrombosis

1992

Other Studies

1 other study(ies) available for dihydroergotamine and Genital Neoplasms, Female

ArticleYear
[Modern aspects relating to prophylaxis against thrombo-embolism in gynaecology and obstetrics (author's transl)].
    Zentralblatt fur Gynakologie, 1981, Volume: 103, Issue:15

    Topics: Age Factors; Aspirin; Coumarins; Dextrans; Dihydroergotamine; Dose-Response Relationship, Drug; Female; Genital Neoplasms, Female; Heparin; Humans; Hysterectomy; Risk; Sex Factors; Thromboembolism

1981